logo

For the Inventor, By the Inventor

Raleigh, NC, United States of America

Lawrence Edward Brieaddy

USPTO Granted Patents = 17

Average Co-Inventor Count = 1.8

ph-index = 8

Forward Citations = 296(Granted Patents)


Company Filing History:

goldMedal11 out of 521 
 
Burroughs Wellcome Co.
 patents
silverMedal6 out of 281 
 
Glaxo Wellcome Inc.
 patents

Years Active: 1976-1999

Loading Chart...
17 patents (USPTO):Explore Patents
1. 5998400 - Hypolipidemic benzothiazepines (1999-12-07),
2. 5910494 - Hypolipidemic 1,4-benzothiazepine-1,1-dioxides (1999-06-08),
3. 5859240 - Hypolipidemic benzothiazepine compounds (1999-01-12),
4. 5817652 - Hypolipidaemic condensed 1,4-thiazepines (1998-10-06),
5. 5723458 - Hypolipidaemic compounds (1998-03-03),
6. 5663165 - Hypolipidaemic benzothiazepine compounds (1997-09-02),
7. 5216028 - Therapeutic uses of a diphenylsulfide compound to treat depression and (1993-06-01),
8. 5104897 - Medical uses of halogen substituted diphenylsulfides (1992-04-14),
9. 5095039 - Diphenylsulfide compound and use (1992-03-10),
10. 4123555 - Sulfide compounds and methods and compositions for treating depression (1978-10-31),
11. 4103020 - Sulfide compounds as antidepressants (1978-07-25),
12. 4095027 - 2-Carbalkoxy-2'-aminocarbonyldiphenyl sulfides (1978-06-13),
13. 4091100 - Sulfide compounds (1978-05-23),
14. 4061863 - 2-Carbalkoxy-2'-cycloalkylaminocarbonyldiphenyl sulfides (1977-12-06),
15. 4056632 - 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use (1977-11-01),

Title: The Innovative Path of Lawrence Edward Brieaddy

Introduction: Lawrence Edward Brieaddy is a renowned inventor based in Raleigh, NC, whose contributions to the field of pharmaceuticals have led to the successful filing of 17 patents. His innovative spirit and dedication to enhancing health outcomes are evident through his groundbreaking work on various chemical compounds.

Latest Patents: Among his most recent patents, Brieaddy is notable for his development of hypolipidemic benzothiazepines, specifically the hypolipidemic 1,4-benzothiazepine-1,1-dioxides. These compounds play a significant role in managing cholesterol levels and demonstrate the potential for improving cardiovascular health.

Career Highlights: Brieaddy has had a distinguished career in the pharmaceutical industry, making significant strides while working with prominent companies such as Burroughs Wellcome Co. and Glaxo Wellcome Inc. His work in these organizations allowed him to push the boundaries of medicinal chemistry, leading to the development of innovative therapeutic solutions.

Collaborations: Throughout his career, Brieaddy has collaborated with esteemed colleagues, including Nariman Bomanshaw Mehta and Gordon Lewis Hodgson, Jr. These partnerships have contributed to his success in patenting essential inventions that address health concerns.

Conclusion: Lawrence Edward Brieaddy's contributions to the pharmaceutical sciences exemplify the impact of innovative thinking on global health. With a strong portfolio of patents and a commitment to research and development, he continues to inspire future inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…